
business
AstraZeneca Announces Higher Q2 Net Profit Due to Robust Cancer Drug Sales
AstraZeneca's net profit increased by over two percent to $2.5 billion in Q2 2026, driven by strong sales in cancer and rare disease medicines.
Topic
Latest news and analysis on “AstraZeneca”.

AstraZeneca's net profit increased by over two percent to $2.5 billion in Q2 2026, driven by strong sales in cancer and rare disease medicines.